杨宁介入医学网

应通过已置入门静脉主支深部的10F导管鞘插入行胃冠状静脉等侧支循环的导管。这是因为导管鞘使导管可自由移动，通过这一导管鞘还可以取出被意外释放的弹簧栓子，而不影响门静脉插管本身。超硬导丝还可通过该10F导管鞘平行于5－6.5F导管插入肠系膜上静脉...

关于标记门静脉 在长期的临床应用中，TIPS介入医生始终在尝试，使这一基本靠蒙的盲目的的操作，变得更为有目标性，从而缩短操作时间并增加其安全性。用于穿刺门静脉标记方法包括术前经皮门脉内植入标志物，作为经颈静脉穿刺门静脉的方向标志；实时超声引导，...

Controlled expansion stents: 控制扩张支架： Recently, a new controlled expansion stent has been introduced into clinical practice by Gore and associates (Viatorr controlled expansion endoprosthesis; VCX, Flagstaff, AZ, United States), whic...

Target PSPG reduction and passive expansion of under dilated TIPS stents: It has been found that barring few exceptions, patients with de novo or worsening HE after TIPS had PSPG of 12 mmHg, while those with rebleeding often had stent dysf...

In advanced stages of cirrhosis, structural, and functional cardiac abnormalities occur. 在肝硬化的晚期，会发生结构上和功能上的心脏异常。 This cirrhosis associated cardiomyopathy (CCM) leads to impaired contractile responsiveness to stress...

Initial studies identified advanced age as an independent predictor of early mortality after TIPS, attributing it to age-related physiologic decline in hepatic functional reserve, which might not be picked up on routine laboratory tests[16...

Extrahepatic surgery is associated with higher postoperative morbidity and mortality in patients with cirrhosis[137]. 肝外手术与肝硬化[137]患者术后发病率和死亡率较高相关。 The reported mortality is between 10% to 30%, while the perioperativ...

Non-tumoral PVT is the most common thrombotic event in patients with cirrhosis, with an annual incidence of up to 12%[127,128]. 非肿瘤性PVT是肝硬化患者中最常见的血栓性事件，每年的发病率高达12%的[127,128]。 Asymptomatic presentation is comm...

Of all cases of cirrhosis-related ascites, only 0.5%-1% is chylous[112]. The underlying mechanism is believed to be excessive hepatic and gastrointestinal lymph flow and pressure secondary to PH, which may lead to spontaneous rupture of ser...

PHG is characterized by vascular ectasia, which appears as a mosaic-like pattern of gastric mucosa on endoscopy[58,59]. PHG的特点是血管扩张，在内镜[58,59]上呈胃黏膜马赛克样模式。 The reported prevalence of PHG ranges from 20%-98% in patien...